Celiac disease
Drug research and approvals for celiac disease: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 59 studies of celiac disease are recruiting on ClinicalTrials.gov, and Health Canada has authorized 8 drug trials for it since 2013.
- Recruiting worldwide: 59
- Trials authorized in Canada: 8
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 59 recruiting on ClinicalTrials.gov ↗- Liver Steatosis in Pediatric CD PatientsNCT06206616 · Not reported · University of Palermo · starts Nov 1, 2027
- Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in AdolescentsNCT07832994 · Not applicable · Cairo University · starts Aug 15, 2026
- Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased…NCT07716488 · Not applicable · Alexandra Miriam Kiess · starts Aug 1, 2026
- Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac…NCT07636382 · Not applicable · University Health Network, Toronto · starts Jun 4, 2026
- Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy (SBRT) in Participants With…NCT07117032 · Phase 1 · Case Comprehensive Cancer Center · starts May 12, 2026
- Nutrition and Physical Activity Education in Children With Celiac DiseaseNCT07750795 · Not applicable · Bahçeşehir University · starts May 1, 2026
- A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac DiseaseNCT07377565 · Phase 1 · Nielsen Fernandez-Becker · starts Apr 29, 2026
- NCWS or IBS/FD in Relatives of CD PatientsNCT07584473 · Not applicable · University of Palermo · starts Apr 1, 2026
- Effect of Adherence to a Gluten-Free Diet on Cognitive and Motor Dual-Task Performance in Adolescents Diagnosed With…NCT07382999 · Not reported · Inonu University · starts Feb 12, 2026
- Efficacy of Symprove Probiotics in Coeliac DiseaseNCT07360106 · Not applicable · Sheffield Teaching Hospitals NHS Foundation Trust · starts Jan 29, 2026
Trials Authorized in Canada
Newest first; search them all in Canada trials| Jun 27, 2024 | A phase 2a/b, randomized, double-blind, placebo-controlled, parallel-group study to investigate the efficacy and safety of subcutaneous amlitelimab in adult…AMLITELIMAB (SAR445229) / VITEN / PROSOLV | SANOFI-AVENTIS CANADA INC | Ongoing |
| Dec 7, 2023 | Phase 2a double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of kan-101 in participants with celiac diseaseKAN-101 | KANYOS BIO INC. (A WHOLLY OWNED SUBSIDIARY OF ANOKION S.A.) | Closed |
| Oct 18, 2022 | A randomized, double-blind, placebo-controlled, phase 2 dose-ranging study to evaluate the efficacy and safety of tak-101 for the prevention of gluten-specific…TAK-101 | Takeda Pharmaceuticals USA | Ongoing |
| Aug 4, 2022 | Restoration of impaired microbiota-mediated aryl hydrocarbon receptor signaling in celiac disease by oral tryptophan supplementation: an exploratory studyTRYPTOPHAN | MCMASTER UNIVERSITY MEDICAL CENTRE | Ongoing |
| Jul 29, 2022 | A phase 2, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of tak-062 for the treatment of active celiac…TAK-062 | Takeda Pharmaceuticals USA | Ongoing |
| Oct 2, 2020 | A phase 2b, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of prv-015 in adult patients with…PRV-015 (AMG 714) | Sanofi | Ongoing |
| Oct 22, 2019 | A phase 3, randomized, double-blind, placebo controlled study to evaluate the efficacy and safety of larazotide for relief of persistent symptoms in patients…LARAZOTIDE | 9 METERS BIOPHARMA, INC. | Closed |
| Dec 27, 2013 | A phase 2b, randomized, double-blind, placebo-controlled, dose-ranging study of alv003 treatment in symptomatic celiac disease patients maintained on a…ALV003 | ALVINE PHARMACEUTICALS INC | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA